Company news

X4 Pharmaceuticals, Inc. news in 2022

X4 Pharmaceuticals, Inc.'s news releases, calls and decks from 2022, newest first.

View company

X4 Pharmaceuticals Prices $65.0 Million Public Offering

December 6, 2022

X4 Pharmaceuticals Announces Proposed Public Offering

December 5, 2022

X4 Pharmaceuticals Announces Positive Top-Line Results from 4WHIM Global, Pivotal Phase 3 Trial of Once-Daily, Oral Mavorixafor in WHIM Syndrome

November 28, 2022

X4 Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update

November 2, 2022

X4 Pharmaceuticals Announces Appointment of Industry Veteran Mark Baldry as Chief Commercial Officer

October 25, 2022

X4 Pharmaceuticals to Report Third Quarter 2022 Financial Results and Host a Conference Call and Webcast to Discuss Important Upcoming Milestones on November 3, 2022

October 19, 2022

X4 Pharmaceuticals Announces New Positive Phase 1b Data Supporting Mavorixafor’s Broad Potential in Chronic Neutropenia (CN)

September 26, 2022

X4 Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

August 3, 2022

X4 Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host a Conference Call and Webcast on August 4, 2022

July 25, 2022

X4 Pharmaceuticals Announces Strategic Prioritization of Programs and Resources Extending Cash Runway Through Expected Key Clinical and Regulatory Milestones

July 19, 2022

X4 Pharmaceuticals Announces $55 Million Private Placement Financing and Debt Facility Amendment Extending Interest-Only Period by up to 12 Months

June 29, 2022

X4 Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

May 11, 2022

X4 Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host a Conference Call and Webcast on May 12, 2022

May 2, 2022

X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

March 16, 2022

X4 Pharmaceuticals to Announce Fourth Quarter 2021 Financial Results and Host a Conference Call and Webcast on March 17, 2022

March 7, 2022

Calls in 2022

Decks in 2022